Teva Pharmaceutical Industries Ltd. (TEVA: Quote) announced the launch of an authorized generic of Actos (pioglitazone-hydrochloride tablets) 15, 30 and 45mg.
Actos is marketed by Takeda Pharmaceuticals U.S.A., Inc. and used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes.
The brand product had annual sales of approximately $2.7 billion in the United States, based on IMS sales data as of June 30, 2012.
Click here to receive FREE breaking news email alerts for Teva Pharmaceutical Industries Limited and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org